Dr. Hassan Z Sheikh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Saint Albans, VT 05478 Phone: 802-524-2141 |
Sheyda Farhoomand Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Saint Albans, VT 05478 Phone: 802-524-2141 |
Jennifer Levasseur, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 164 Swanton Rd, Saint Albans, VT 05478 Phone: 802-524-6543 |
Dr. Matthew Ryan Sicotte, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 164 Swanton Rd, Saint Albans, VT 05478 Phone: 802-524-6543 Fax: 802-524-7269 |
Sally Hogan Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 170 Swanton Rd, Saint Albans, VT 05478 Phone: 802-524-2918 Fax: 802-524-3517 |
Karriann Ruggiero, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Saint Albans, VT 05478 Phone: 802-524-2141 Fax: 802-524-2142 |
Dr. Cameron Montgomery, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St Ste 23, Saint Albans, VT 05478 Phone: 802-524-2141 Fax: 802-524-2142 |
Jessica Aboelezz Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 Tuckers Way, Saint Albans, VT 05478 Phone: 802-528-4118 |
Ryan Marquis, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Saint Albans, VT 05478 Phone: 802-524-2141 |
Eric Jarvis, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 164 Swanton Rd, Saint Albans, VT 05478 Phone: 802-524-6543 |
Allyson Mason, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Saint Albans, VT 05478 Phone: 802-524-2141 |
Mr. Pierre Malki, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Suite 23, Saint Albans, VT 05478 Phone: 802-524-2141 |
Mrs. Angela Anne Mccarthy, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 Tuckers Way, Saint Albans, VT 05478 Phone: 802-528-4118 |
Dr. Lauren Brady, RPH, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 170 Swanton Rd, Saint Albans, VT 05478 Phone: 802-524-2918 Fax: 802-524-3517 |
Hayley Egan Paige, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St Ste 23, Saint Albans, VT 05478 Phone: 802-524-2141 Fax: 802-524-2142 |
Jason James Brower, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 277 Swanton Rd, Saint Albans, VT 05478 Phone: 802-524-2217 Fax: 802-524-3273 |
Mark Coons, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Saint Albans, VT 05478 Phone: 802-524-2141 Fax: 802-524-2142 |
Quynh Bui Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St Ste 23, Saint Albans, VT 05478 Phone: 802-524-2141 |
Paula Laplant, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Suite 30, Saint Albans, VT 05478 Phone: 802-524-2141 |
Melinda Sue Malone, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 277 Swanton Rd, Saint Albans, VT 05478 Phone: 802-524-2217 |
News Archive
SAGE today announced they are launching a further three broad-spectrum open access journals - SAGE Open Medicine, SAGE Open Medical Case Reports and SAGE Open Engineering.
Melanoma is the deadliest form of skin cancer, killing more than 8,000 in the U.S. each year. Approximately 40 percent of advanced melanoma tumors are driven to grow by the presence of mutations in a gene known as the BRAF gene.
VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension in Prague, Czech Republic.
A new analysis has found that lumpectomy plus radiation for early breast cancer may provide patients with a better chance of survival than mastectomy. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the results provide confidence in the efficacy of breast-conserving treatments even among patients with aggressive, early disease.
Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.
› Verified 1 days ago